Home  »  Finance   »  Catalyst Biosciences Inc. (CBIO) on Track to Reach...

Catalyst Biosciences Inc. (CBIO) on Track to Reach $3.00 in a Year

Catalyst Biosciences Inc. (NASDAQ: CBIO) is -9.05% lower on its value in year-to-date trading and has touched a low of $0.06 and a high of $0.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CBIO stock was last observed hovering at around $0.27 in the last trading session, with the day’s gains setting it 0.03% off its average median price target of $3.00 for the next 12 months. It is also 90.0% off the consensus price target high of $3.00 offered by 2 analysts, but current levels are 90.0% higher than the price target low of $3.00 for the same period.

Currently trading at $0.30, the stock is -8.75% and -9.52% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.61 million and changing 10.00% at the moment leaves the stock 10.23% off its SMA200. CBIO registered 185.16% gain for a year compared to 6-month gain of 3.69%.

5 Undervalued Stocks For 2023

Approximately 544 miles north of Las Vegas lies what's been dubbed "the biggest lithium deposit in the US." One tiny company stands to be the biggest beneficiary because lithium "faces a long-term supply shortage," according to Barron's. This company, however, is sitting on a goldmine opportunity as it plans to produce 30,000 tonnes per annum over the next 3.5 years from this single deposit. Supplying the electric vehicle boom and potentially driving its stock price off the charts. But this is just one of the opportunities we have researched in our free report. The other four companies have just as much potential.

Click here to download your Free Copy…


The stock witnessed a -4.05% loss in the last 1 month and extending the period to 3 months gives it a -16.82%, and is 16.61% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.12% over the week and 10.20% over the month.

Catalyst Biosciences Inc. (CBIO) has around 45 employees, a market worth around $10.46M and $3.20M in sales. Current P/E ratio is 0.79. Distance from 52-week low is 421.28% and -26.19% from its 52-week high. The company has generated returns on investments over the last 12 months (-213.90%).

Catalyst Biosciences Inc. (CBIO) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Catalyst Biosciences Inc. (CBIO) is a “Hold”. 2 analysts offering their recommendations for the stock have an average rating of 2.70, where 2 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Catalyst Biosciences Inc. is expected to release its quarterly report on 05/04/2023.The EPS is expected to grow by 2.10% this year.

Catalyst Biosciences Inc. (CBIO) Top Institutional Holders

The shares outstanding are 31.48M, and float is at 27.91M with Short Float at 3.43%.

Catalyst Biosciences Inc. (CBIO) Insider Activity

A total of 3 insider transactions have happened at Catalyst Biosciences Inc. (CBIO) in the last six months, with sales accounting for 0 and purchases happening 3 times.

Catalyst Biosciences Inc. (CBIO): Who are the competitors?

The company’s main competitors (and peers) include AstraZeneca PLC (AZN) that is trading 12.15% up over the past 12 months and Johnson & Johnson (JNJ) that is 2.09% higher over the same period. AbbVie Inc. (ABBV) is 11.90% up on the 1-year trading charts.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts